Amphastar Pharmaceuticals, Inc. Tax Withholding Paid on Stock Awards
Amphastar Pharmaceuticals, Inc. (AMPH) reported Tax Withholding Paid on Stock Awards of $1.34 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2016-11-09
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2016-09-30 was $100.00K, a 13.79% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2016-06-30 was $159.00K, a 5.92% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2016-03-31 was $1.08M, a 89.34% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2015-12-31 was -$236.00K.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2015 was $621.00K, a 59.64% increase from fiscal 2014.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2014 was $389.00K, a 95.48% increase from fiscal 2013.
- Amphastar Pharmaceuticals, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2013 was $199.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2016-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $259.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.34M 10-Q · filed 2016-11-09 | $1.11M derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | $159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.24M 10-Q · filed 2016-08-09 | $1.01M derived: sum of 3 quarters · filed 2016-08-09 | $1.12M derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-03-31 | $1.08M 10-Q · filed 2016-05-10 | $847.00K derived: sum of 2 quarters · filed 2016-05-10 | $963.00K derived: sum of 3 quarters · filed 2016-11-09 | $1.13M derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$120.00K derived: sum of 2 quarters · filed 2016-11-09 | $49.00K derived: sum of 3 quarters · filed 2016-11-09 | $621.00K 10-K · filed 2016-03-15 |
| 2015-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $285.00K derived: sum of 2 quarters · filed 2016-11-09 | $857.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $741.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $572.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $389.00K 10-K · filed 2016-03-15 | |||
| 2013-12-31 | $199.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |